SPRY4 and gastric cancer: SPRY4-TI1 was found to promote cell proliferation, migration and invasion via regulating epithelial–mesenchymal transition in various types of cancers including gastric cancer, colorectal cancer, ESCC, glioma and NSCLC [12, 16–19].